The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter randomized phase II study of nivolumab in combination with gemcitabine/cisplatin or ipilimumab as first-line therapy for patients with advanced unresectable biliary tract cancer (BilT-01).
 
Vaibhav Sahai
Consulting or Advisory Role - AstraZeneca; Celgene; Halozyme; Incyte; Ipsen; Klus Pharma; Newlink Genetics; QED Therapeutics
Research Funding - Agios (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); FibroGen (Inst); Halozyme (Inst); Incyte (Inst); Ipsen (Inst); MedImmune (Inst); Rafael Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - ASCO; FibroGen; FibroGen
 
Kent A. Griffith
No Relationships to Disclose
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Array BioPharma; Boston Biomedical; Ipsen
Speakers' Bureau - Bristol-Myers Squibb; Ipsen
Research Funding - Agios (Inst); ArQule (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); CASI Pharmaceuticals (Inst); Celgene (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); ImmuneSensor Therapeutics (Inst); MedImmune (Inst); Merck Serono (Inst); Sillajen (Inst); Tolero Pharmaceuticals (Inst)
 
Walid Labib Shaib
Honoraria - Ipsen; Ipsen
Consulting or Advisory Role - Blueprint Medicines; Blueprint Medicines; Mylan
Research Funding - ArQule (Inst); Basilea (Inst); Lexicon (Inst); Lilly (Inst)
 
Devalingam Mahalingam
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; EMD Serono
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Eisai; Exelixis; Genentech
Research Funding - Merck KGaA; Oncolytics
 
David Bing Zhen
No Relationships to Disclose
 
Dustin A. Deming
Consulting or Advisory Role - Acrotech Biopharma; Array BioPharma; Bayer; Bristol-Myers Squibb; Genentech/Roche; Novocure; Promega; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Revolution Medicines (Inst)
 
Sumi Dey
No Relationships to Disclose
 
Mishal Mendiratta-Lala
No Relationships to Disclose
 
Mark Zalupski
Research Funding - AstraZeneca/MedImmune; Halozyme; Merck; Newlink Genetics/Pharmatech; Oncomed; Seagen